Member of the Advisory Board
In 2019, Daniela Bosshardt was elected Chairwoman of the Board of Directors of Galenica, a Swiss publicly traded healthcare provider, a board she joined in 2017. Since 2008, she has been a member of the board of directors of Reprisk Ltd., an ESG data science company based in Zurich. Daniela is a trustee of the Swiss think tank Avenir Suisse.
Daniela is formerly a board member of pharmaceutical company Vifor Pharma (2008-2019), the start-up investment and venture capital firm investiere.ch - Verve Capital Partners (2017-2019) and the dental implant company Nobel Biocare (2010-2014). Daniela was a financial analyst at Bank am Bellevue (1998-2002) and M2 Capital (2003-2004). Since 2004, Daniela, in her capacity as the founding partner of Bosshardt Consulting, has worked as an independent consultant in the areas of financial analysis and business development for corporates and investment managers, including for some larger Family Offices, active in the pharmaceutical, medical technology and biotechnology sectors. After completing her studies in pharmacy, Daniela practiced as a pharmacist for two years.
In 1996, Daniela received her Federal Diploma in Pharmacy from the Swiss Institute of Technology, Zürich (ETHZ).